Time In Range with Diabetes - Reviewing CGM (Continuous Glucose Monitor) Clinical Goals
ฝัง
- เผยแพร่เมื่อ 25 ก.ค. 2024
- In this episode, Dr. Diana Isaacs discusses time-in-range goals for CGMs, review CGM graphs, and provides tips for people with diabetes wearing CGMs.
Follow Diana Isaacs on Twitter @DianaMIsaacs
Connect with That Diabetes Guy:
Twitter: ThatDiabetesGuy
Instagram: thatdiabetesguy
Gmail: ThatDiabetesGuy@gmail.com
Other reputable websites:
diaTribe.org/timeinrange
diabetes.org/diabetes
cdc.gov/diabetes/index.html
I'm on the Medtronic 770 which sends data to my cell phone. I can check my daily percent in range all day long. Thus, it's so much easier to stay in range that way. Some days are roller coasters, but my 30 day time-in-range right now is 91%. I'm retired, so that helps. I've had T1D for 55 years and am doing fine, for which I am so grateful. Your presentation was excellent. You obviously understand CGM numbers. I've had a CGM for 2 years and a pump/CGM for 4 years. Before that I was MDI, multiple daily injections, for a lot of years, testing my blood glucose at least 6 times a day. When the BG meters came out, that was so great, eliminating the urine tests which were not accurate. Diabetes is do-able. I'm 71 yrs and am planning to live a lot longer.
wish my nurse would be like that. she wants perfection all the time, and its so hard to do that. I am 69% in range so im happy with that. Ive only had my libre just over two weeks ;)
Very helpful thx
appreciate this! was just wondering what % i should be shooting for in range. perfect timing :)
For adults without any other special considerations, the recommendation is to spend 70% of the time (or more) between 70-180 mg/dL. However, you should work together with your provider to establish your own personalized goal. Thanks for your question!
Nice video, I love my Libre 14days and Blucon cgm together, both helps me to manage my blood glucose. My Blucon give me alarms on my and my patners phone when I’m high or low so that’s nice.
Not sure where you live, but US just approved Librelink for Libre 2 CGMs with smart phones this week. Keep an eye out for the app update sometime in the next few days per Abbott.
This was just the information I have been looking for. It's one thing to have a CGM, but another thing altogether to interpret it properly.
Quick question: Is the 180 to 70 time in range the same for type 2 diabetes as it is for type 1?
By the way...I have never left a comment before on any TH-cam video. I just had to this time because of the great service you have done. Thanks!!
The time-in-range consensus goals are the same for both type 1 and type 2 diabetes (not pregnant). However, a provider can always advise different goals for individualized care.
Very helpful video
Seems like these ranges are for diabetics not for persons with normal metabolism.
I wear a cgm due to pre diabetes determined by my doctor but who would not prescribe a cgm.
I went on my own and acquired one.
The education it gave me on foods that trigger spikes was enormous.
I have managed my time in range to 98% at 70 to 140.
I cannot believe that 180 is ever considered good and especially only 70% of the time.
Would be nice to know what Optimal is.
After all that is what we should be using as a target
Below 180 is good for diabetics, because of their medication. Aiming for less could result in low blood sugar, which could be fatal.
Correct, these glucose ranges are referenced from a consensus statement regarding Time-in-Range for people with diabetes. For people without diabetes or pre-diabetes, ideally, you want fasting bg less than 100 mg/dL and post-meal spikes 1-2 hrs after to always be less than 140 mg/dL.
I assume that the 70 - 180 mg /dl target range on the CGM is pre-programmed and is not based upon the alert levels set by the user?
Most CGM systems default the "time-in-range" of 70-180 mg/dL, but the reports can be adjusted in the settings for each device if you want different target ranges. Again, the time-in-range goals include fasting and post-meal spike bg goals based on a consensus statement by leading endocrine providers.